The p16/RB1 tumor suppressor pathway is inactivated in the vast majority, if not all, human cancers. The current paradigm is that p16 and RB1 function in a linear pathway to suppress tumorigenesis; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback